REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.62
+0.21 (2.83%)
At close: Dec 20, 2024, 4:00 PM
7.71
+0.09 (1.18%)
After-hours: Dec 20, 2024, 7:01 PM EST
REGENXBIO Employees
REGENXBIO had 344 employees as of December 31, 2023. The number of employees decreased by 57 or -14.21% compared to the previous year.
Employees
344
Change (1Y)
-57
Growth (1Y)
-14.21%
Revenue / Employee
$245,137
Profits / Employee
-$694,201
Market Cap
377.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
AngioDynamics | 748 |
Sana Biotechnology | 328 |
Prime Medicine | 234 |
Personalis | 225 |
Alpha Teknova | 211 |
Taysha Gene Therapies | 52 |
GH Research | 49 |
RGNX News
- 15 days ago - Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 4 weeks ago - REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATA - PRNewsWire
- 5 weeks ago - REGENXBIO to Host Webcast Discussing Pivotal Program and First Functional Data from the AFFINITY DUCHENNE® Trial of RGX-202 - PRNewsWire
- 6 weeks ago - REGENXBIO Inc. (RGNX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational Updates - PRNewsWire
- 6 weeks ago - REGENXBIO to Participate in Upcoming Investor Conferences - PRNewsWire
- 7 weeks ago - REGENXBIO: With Additional MPS II Data, Program Advancement Remains On Track - Seeking Alpha
- 7 weeks ago - REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational Highlights - PRNewsWire